Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

March 31, 2020

Conditions
Atrial FibrillationInflammation
Interventions
DEVICE

Parasym device

Trial Locations (1)

73104

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Oklahoma

OTHER

NCT02548754 - Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation | Biotech Hunter | Biotech Hunter